Mosanna Therapeutics closed a Seed round (amount undisclosed) in Jul 2022. The company is based in Zurich, Switzerland. Investors in the round: Forty51 Ventures. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
